Rezolute, Inc. (RZLT) Financial Statements (2026 and earlier)

Company Profile

Business Address 275 SHORELINE DRIVE, SUITE 500
REDWOOD CITY, CA 94065
State of Incorp. NV
Fiscal Year End June 30
Industry (SIC) 2834 - Pharmaceutical Preparations (benchmarking)
More info Complete Financial Analysis Financial Benchmarking

Balance Sheet (Statement of Financial Position) (USD)

9/30/2025
MRQ
6/30/2025
12/31/2024
MRQ
6/30/2024
6/30/2023
6/30/2022
6/30/2021
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments167,858,00096,540,000126,874,000101,896,000150,410,00041,047,000
Cash and cash equivalent94,107,0008,932,00070,396,00016,036,000150,410,00041,047,000
Short-term investments73,751,00087,608,00056,478,00085,860,000  
Receivables    300,000  
Debt securities, available-for-sale, accrued interest, after allowance for credit loss400,000   
Other undisclosed current assets3,287,0002,154,0001,379,0002,714,0001,694,000946,000
Total current assets:171,145,00098,694,000128,653,000104,910,000152,104,00041,993,000
Noncurrent Assets
Operating lease, right-of-use asset1,348,0001,619,0001,880,0002,054,000152,000396,000
Property, plant and equipment72,00087,000103,000139,00016,00029,000
Long-term investments and receivables  8,775,000263,00016,470,000  
Long-term investments  8,775,000263,00016,470,000  
Deposits noncurrent assets2,925,0002,832,0001,838,000148,000148,000 
Deferred costs      191,000
Total noncurrent assets:4,345,00013,313,0004,084,00018,811,000316,000616,000
TOTAL ASSETS:175,490,000112,007,000132,737,000123,721,000152,420,00042,609,000
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities8,078,0007,128,0006,713,0004,152,0001,375,0001,354,000
Employee-related liabilities 77,000
Accounts payable5,809,0003,149,0004,901,0003,269,0001,132,0001,035,000
Accrued liabilities2,269,0003,979,0001,812,000883,000243,000242,000
Other liabilities     979,000349,000
Other undisclosed current liabilities3,834,0003,480,0002,893,0001,048,000108,000265,000
Total current liabilities:11,912,00010,608,0009,606,0005,200,0002,462,0001,968,000
Noncurrent Liabilities
Long-term debt and lease obligation:     80,000187,000
Liabilities, other than long-term debt983,0001,333,0001,660,0001,937,000  
Operating lease, liability983,0001,333,0001,660,0001,937,00080,000187,000
Other undisclosed noncurrent liabilities468,000477,000468,000412,000327,00014,168,000
Total noncurrent liabilities:1,451,0001,810,0002,128,0002,349,000487,00014,542,000
Total liabilities:13,363,00012,418,00011,734,0007,549,0002,949,00016,510,000
Equity
Equity, attributable to parent162,127,00099,589,000121,003,000116,172,000149,471,00026,099,000
Common stock87,00061,00053,00037,00034,0008,000
Additional paid in capital565,903,000460,016,000450,473,000377,471,000358,635,000194,229,000
Accumulated other comprehensive income (loss)(7,000)64,000(79,000)(351,000)  
Accumulated deficit(403,856,000)(360,552,000)(329,444,000)(260,985,000)(209,198,000)(168,138,000)
Total equity:162,127,00099,589,000121,003,000116,172,000149,471,00026,099,000
TOTAL LIABILITIES AND EQUITY:175,490,000112,007,000132,737,000123,721,000152,420,00042,609,000

Income Statement (P&L) (USD)

9/30/2025
TTM
6/30/2025
12/31/2024
TTM
6/30/2024
6/30/2023
6/30/2022
6/30/2021
Gross profit:      (765,000)
Operating expenses(79,894,000)(73,336,000)(70,423,000)(55,990,000)(41,843,000)(22,894,000)
Other undisclosed operating income      765,000
Operating loss:(79,894,000)(73,336,000)(70,423,000)(55,990,000)(41,843,000)(22,894,000)
Nonoperating income5,482,0002,202,0001,964,0004,203,000783,0001,992,000
Investment income, nonoperating (1,968,000) (5,000)6,545,0001,789,000
Interest and debt expense     (1,771,000)(375,000)
Loss from continuing operations:(74,412,000)(71,134,000)(68,459,000)(51,787,000)(42,831,000)(21,277,000)
Loss before gain (loss) on sale of properties:(42,831,000)(21,277,000)
Other undisclosed net income     1,771,000375,000
Net loss available to common stockholders, basic:(74,412,000)(71,134,000)(68,459,000)(51,787,000)(41,060,000)(20,902,000)
Other undisclosed net loss available to common stockholders, diluted     (4,070,000) 
Net loss available to common stockholders, diluted:(74,412,000)(71,134,000)(68,459,000)(51,787,000)(45,130,000)(20,902,000)

Comprehensive Income (USD)

9/30/2025
TTM
6/30/2025
12/31/2024
TTM
6/30/2024
6/30/2023
6/30/2022
6/30/2021
Net loss:(74,412,000)(71,134,000)(68,459,000)(51,787,000)(41,060,000)(20,902,000)
Comprehensive loss:(74,412,000)(71,134,000)(68,459,000)(51,787,000)(41,060,000)(20,902,000)
Other undisclosed comprehensive income (loss), net of tax, attributable to parent72,000112,000272,000(351,000)  
Comprehensive loss, net of tax, attributable to parent:(74,340,000)(71,022,000)(68,187,000)(52,138,000)(41,060,000)(20,902,000)

Statements Sources

The financial statements are based on the Company's filings with the U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: